213 related articles for article (PubMed ID: 9781153)
1. [Treatment of resistant forms and recurrence of Hodgkin's disease].
Diviné M; Reyes F
Rev Prat; 1998 May; 48(10):1087-91. PubMed ID: 9781153
[TBL] [Abstract][Full Text] [Related]
2. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
[TBL] [Abstract][Full Text] [Related]
3. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
6. [Primary treatment of advanced Hodgkin's disease].
Illés A; Udvardy M; Molnár Z
Orv Hetil; 2005 Jan; 146(5):195-202. PubMed ID: 15773586
[TBL] [Abstract][Full Text] [Related]
7. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Tsushita K; Utsumi M; Shimoyama M
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
[TBL] [Abstract][Full Text] [Related]
8. [Primary treatment of early stage Hodgkin's disease].
Molnár Z; Esik O; Illés A
Orv Hetil; 2005 Jan; 146(2):57-61. PubMed ID: 15724953
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors and treatment of advanced Hodgkin's disease].
Fermé C
Rev Prat; 1998 May; 48(10):1082-6. PubMed ID: 9781152
[TBL] [Abstract][Full Text] [Related]
10. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
11. High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffuse lung injury syndromes.
Frankovich J; Donaldson SS; Lee Y; Wong RM; Amylon M; Verneris MR
Biol Blood Marrow Transplant; 2001; 7(1):49-57. PubMed ID: 11215699
[TBL] [Abstract][Full Text] [Related]
12. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
Bonadonna G; Bonfante V; Viviani S; Di Russo A; Villani F; Valagussa P
J Clin Oncol; 2004 Jul; 22(14):2835-41. PubMed ID: 15199092
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors and treatment of localized Hodgkin's disease].
Carde P; Cosset JM
Rev Prat; 1998 May; 48(10):1075-81. PubMed ID: 9781151
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
Popat U; Hosing C; Saliba RM; Anderlini P; van Besien K; Przepiorka D; Khouri IF; Gajewski J; Claxton D; Giralt S; Rodriguez M; Romaguera J; Hagemeister F; Ha C; Cox J; Cabanillas F; Andersson BS; Champlin RE
Bone Marrow Transplant; 2004 May; 33(10):1015-23. PubMed ID: 15048145
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin's disease.
Diehl V; Josting A
Cancer J; 2000 Apr; 6 Suppl 2():S150-8. PubMed ID: 10803830
[TBL] [Abstract][Full Text] [Related]
17. Management of stage I and II Hodgkin's disease.
Farah R; Weichselbaum RR
Hematol Oncol Clin North Am; 1989 Jun; 3(2):253-63. PubMed ID: 2663826
[TBL] [Abstract][Full Text] [Related]
18. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
[TBL] [Abstract][Full Text] [Related]
19. Substaging of stage III Hodgkin's disease.
Farah R; Weichselbaum RR
Hematol Oncol Clin North Am; 1989 Jun; 3(2):277-86. PubMed ID: 2663828
[TBL] [Abstract][Full Text] [Related]
20. New strategies for the treatment of advanced-stage Hodgkin's lymphoma.
Diehl V; Engert A; Re D
Hematol Oncol Clin North Am; 2007 Oct; 21(5):897-914. PubMed ID: 17908627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
